These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27881367)

  • 1. When is a point of view a conflict of interest?
    Lenzer J
    BMJ; 2016 Nov; 355():i6194. PubMed ID: 27881367
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 3. US advisory panellists on drug's safety had ties to manufacturers.
    Lenzer J; Epstein K
    BMJ; 2012 Jan; 344():e244. PubMed ID: 22234908
    [No Abstract]   [Full Text] [Related]  

  • 4. The Ethical Challenges of Compassionate Use.
    Caplan AL; Ray A
    JAMA; 2016 Mar; 315(10):979-80. PubMed ID: 26868205
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA revamps committee conflict-of-interest rules.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Oct; 98(19):1354-5. PubMed ID: 17018777
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflicts cause FDA to review advisory committees.
    Kondro W
    CMAJ; 2006 Jul; 175(1):23. PubMed ID: 16818900
    [No Abstract]   [Full Text] [Related]  

  • 7. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study.
    Schwartz JL
    N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733
    [No Abstract]   [Full Text] [Related]  

  • 8. US dietary committee criticised for ties to industry.
    Nelson R
    Lancet; 2003 Sep; 362(9386):808. PubMed ID: 13678891
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA needs a more "nuanced" approach to advisers' conflicts of interest, researchers say.
    Dyer O
    BMJ; 2014 Sep; 349():g5665. PubMed ID: 25227397
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 11. Group says FDA, advisory panels show bias toward drug approvals.
    Vedantam S
    Washington Post; 2006 Aug; ():A13. PubMed ID: 16941783
    [No Abstract]   [Full Text] [Related]  

  • 12. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.
    Lammers A; Edmiston J; Kaestner V; Prasad V
    Mayo Clin Proc; 2017 Jul; 92(7):1164-1166. PubMed ID: 28688469
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration.
    Abola MV; Prasad V
    JAMA Intern Med; 2016 Mar; 176(3):389-91. PubMed ID: 26831527
    [No Abstract]   [Full Text] [Related]  

  • 14. Hidden conflicts?
    Piller C
    Science; 2018 Jul; 361(6397):16-20. PubMed ID: 29976808
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of Interest of Public Speakers at Meetings of the Anesthetic and Analgesic Drug Products Advisory Committee.
    McCoy MS; Pagán O; Donohoe G; Kanter GP; Litman RS
    JAMA Intern Med; 2018 Jul; 178(7):996-997. PubMed ID: 29710219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflict of Interest in Practice Guidelines Panels.
    Sox HC
    JAMA; 2017 May; 317(17):1739-1740. PubMed ID: 28464160
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
    Roberts W; Jellison S; Wayant C; Vassar M
    BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ejecting the FDA from the courtroom.
    Lancet; 2004 Aug 21-27; 364(9435):638. PubMed ID: 15325808
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.